Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 261 articles:
HTML format



Single Articles


    May 2020
  1. BHAT S, Farraye FA, Moss A
    Roles of Clinical Pharmacists in Caring for Patients with Inflammatory Bowel Disease during COVID-19.
    Gastroenterology. 2020 May 18. pii: S0016-5085(20)30677.
    PubMed    


  2. MITSIALIS V, Wall S, Liu P, Ordovas-Montanes J, et al
    Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Gastroenterology. 2020 May 16. pii: S0016-5085(20)30658.
    PubMed     Abstract available


  3. KOTZE PG, Peyrin-Biroulet L, Danese S
    Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic.
    Gastroenterology. 2020 May 15. pii: S0016-5085(20)30660.
    PubMed    


  4. KRZYSZTOF NJ, Christoffer LJ, Rahul K, Ricanek P, et al
    Age, inflammation and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease.
    Gastroenterology. 2020 May 12. pii: S0016-5085(20)30653.
    PubMed    


  5. MACALUSO FS, Orlando A
    Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19?
    Gastroenterology. 2020 May 11. pii: S0016-5085(20)30619.
    PubMed    


  6. LO CH, Lochhead P, Khalili H, Song M, et al
    Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative Colitis.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30603.
    PubMed     Abstract available


  7. GOWER-ROUSSEAU C, Fumery M, Pariente B
    Inflammatory bowel disease and the SARS-CoV-2 pandemic: more speed, less haste.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30605.
    PubMed    


  8. GUBATAN J, Levitte S, Balabanis T, Patel A, et al
    SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California.
    Gastroenterology. 2020 May 6. pii: S0016-5085(20)30601.
    PubMed    


    April 2020
  9. D'AMICO F, Danese S, Peyrin-Biroulet L
    Inflammatory bowel disease management during the COVID-19 outbreak: a survey from the European Crohn's and Colitis Organization (ECCO).
    Gastroenterology. 2020 Apr 30. pii: S0016-5085(20)30578.
    PubMed    


  10. RODRIGUEZ-LAGO I, Ramirez de la Piscina P, Elorza A, Merino O, et al
    Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain).
    Gastroenterology. 2020 Apr 21. pii: S0016-5085(20)30560.
    PubMed    


  11. PARIGI TL, D'Amico F, Danese S
    Upadacitinib for Crohn's disease and ulcerative colitis treatment: hitting the selective JAKpot.
    Gastroenterology. 2020 Apr 17. pii: S0016-5085(20)30517.
    PubMed    


  12. HOLMER AK, Dulai PS
    Deep Learning Accurately Predicts Endoscopic and Histologic Remission in Ulcerative Colitis - What the Eye Doesn't See, the Artificial Mind Does Actually Know.
    Gastroenterology. 2020 Apr 11. pii: S0016-5085(20)30481.
    PubMed    


  13. RUBIN DT, Feuerstein JD, Wang AY, Cohen RD, et al
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
    Gastroenterology. 2020 Apr 10. pii: S0016-5085(20)30482.
    PubMed     Abstract available


  14. RUBIN DT, Abreu MT, Rai V, Siegel CA, et al
    Management of Patients with Crohn's Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting.
    Gastroenterology. 2020 Apr 6. pii: S0016-5085(20)30465.
    PubMed    


  15. FAYE AS, Colombel JF
    Age is Just a Number: How Frailty May Predict Outcomes Within Inflammatory Bowel Disease.
    Gastroenterology. 2020 Apr 2. pii: S0016-5085(20)30456.
    PubMed    



  16. Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.
    Gastroenterology. 2020;158:1462-1463.
    PubMed    


    March 2020
  17. BAMIAS G, Rivera-Nieves J, Mantzaris GJ
    Efficacy of IL12/23 blockade expands our therapeutic targets and challenges the old dogma in ulcerative colitis.
    Gastroenterology. 2020 Mar 18. pii: S0016-5085(20)30366.
    PubMed     Abstract available


  18. SPENCER EA, Helmus D, Telesco S, Colombel JF, et al
    Inflammatory Bowel Disease Clusters Within Affected Sibships in Ashkenazi Jewish Multiplex Families.
    Gastroenterology. 2020 Mar 18. pii: S0016-5085(20)30365.
    PubMed    


  19. FEUERSTEIN JD, Isaacs KL, Schneider Y, Siddique SM, et al
    Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.
    Gastroenterology. 2020 Mar 10. pii: S0016-5085(20)30333.
    PubMed    


  20. DANESE S, Rimola J, Siegelman J
    Reply.
    Gastroenterology. 2020;158:1177-1178.
    PubMed    


  21. MACALUSO FS, Castiglione F, Rispo A, Orlando A, et al
    The VERSIFY Trial: What About Ultrasound Assessment?
    Gastroenterology. 2020;158:1176-1177.
    PubMed    


  22. GAUSMAN V, McNeill MB, Balzora S
    Facing Crohn's: A Rare Association.
    Gastroenterology. 2020;158:829-830.
    PubMed    


  23. APOSTOLOV R, Nicolaides S, Vasudevan A
    Complex Fistulizing Crohn's Disease.
    Gastroenterology. 2020;158:827-828.
    PubMed    


  24. PITTAYANON R, Lau JT, Leontiadis GI, Tse F, et al
    Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.
    Gastroenterology. 2020;158:930-946.
    PubMed     Abstract available


  25. JARDINE S, Anderson S, Babcock S, Leung G, et al
    Drug Screen Identifies Leflunomide for Treatment of Inflammatory Bowel Disease Caused by TTC7A Deficiency.
    Gastroenterology. 2020;158:1000-1015.
    PubMed     Abstract available


    February 2020
  26. SANDBORN WJ, Ghosh S, Panes J, Schreiber S, et al
    Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis.
    Gastroenterology. 2020 Feb 21. pii: S0016-5085(20)30241.
    PubMed     Abstract available


  27. PEREZ-JELDRES T, Alvarez-Lobos M, Nieves JR, Villablanca EJ, et al
    The cell circuitry of ulcerative colitis, a new view for a highly complex disease.
    Gastroenterology. 2020 Feb 14. pii: S0016-5085(20)30228.
    PubMed    


  28. TAKENAKA K, Ohtsuka K, Fujii T, Negi M, et al
    Development and Validation of a Deep Neural Network for Accurate Evaluation of Endoscopic Images From Patients with Ulcerative Colitis.
    Gastroenterology. 2020 Feb 11. pii: S0016-5085(20)30212.
    PubMed     Abstract available


  29. AGRAWAL M, Ungaro RC, Colombel JF
    New Blood Marker of Endoscopic Disease Activity-A Step Forward in Treating Crohn's Disease to Target?
    Gastroenterology. 2020;158:463-465.
    PubMed    


  30. FRITSCH J, Abreu MT
    Exposing the Achilles Heel of Antibiotic Therapy for Pouchitis Using Microbial Function and Composition.
    Gastroenterology. 2020;158:470-472.
    PubMed    


  31. D'HAENS G, Kelly O, Battat R, Silverberg MS, et al
    Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.
    Gastroenterology. 2020;158:515-526.
    PubMed     Abstract available


  32. SONDHI AR, Nayak LJ, Mowers J
    Cachexia, Colitis, and Cancer.
    Gastroenterology. 2020;158:488-490.
    PubMed    


    January 2020
  33. CHIBA M, Tsuji T, Komatsu M
    How to Optimize Effects of Infliximab in Inflammatory Bowel Disease: Incorporation of Plant-based Diet: Infliximab Optimization Needs Dietary Fiber.
    Gastroenterology. 2020 Jan 14. pii: S0016-5085(20)30106.
    PubMed    


  34. FEUERSTEIN JD, Isaacs KL, Schneider Y, Siddique SM, et al
    AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30018.
    PubMed    


  35. HAMMOUDI N, Bondeelle L, Gornet JM
    An unusual case of chronic cough revealing ulcerative colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30083.
    PubMed    


  36. KENNEDY J, Satsangi J, Chapman TP
    Just another flare of ulcerative colitis?
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30094.
    PubMed    


  37. SINGH S, Allegretti JR, Siddique SM, Terdiman JP, et al
    AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30019.
    PubMed     Abstract available


  38. LIM J, Hammami MB, Mahadevan U
    Infliximab Use in a Child with Ulcerative Colitis and Prior in utero Exposure to Infliximab.
    Gastroenterology. 2020 Jan 8. pii: S0016-5085(20)30012.
    PubMed    


  39. KHALILI H, Burke KE, Roelstraete B, Sachs MC, et al
    Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study.
    Gastroenterology. 2020 Jan 8. pii: S0016-5085(20)30008.
    PubMed     Abstract available


  40. PARK SH, Park SH
    Simplified Magnetic Resonance Index of Activity for Crohn's Disease-Let's Try to Kick It Up a Notch.
    Gastroenterology. 2020;158:281-282.
    PubMed    


  41. WILLIET N, Jardin S, Roblin X
    The Simplified Magnetic Resonance Index of Activity (MARIA) for Crohn's Disease Is Strongly Correlated With the MARIA and Clermont Score: An External Validation.
    Gastroenterology. 2020;158:282-283.
    PubMed    


  42. SAZONOVS A, Kennedy NA, Moutsianas L, Heap GA, et al
    HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
    Gastroenterology. 2020;158:189-199.
    PubMed     Abstract available


  43. SEIDELIN JB, Riis LB, Butt RA
    Crohn's Disease With Progressive Renal Impairment.
    Gastroenterology. 2020;158:58-59.
    PubMed    


  44. GORDON IO, Bettenworth D, Bokemeyer A, Srivastava A, et al
    Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review.
    Gastroenterology. 2020;158:137-150.
    PubMed     Abstract available


    December 2019
  45. DANESE S
    New Drugs In The Ulcerative Colitis Pipeline: Prometheus Unbound.
    Gastroenterology. 2019 Dec 17. pii: S0016-5085(19)41924.
    PubMed    


  46. GRIMAUD F, Serrero M, Magalon J
    Adipose-Derived Therapeutic Products for the Management of Refractory Crohn's Fistula.
    Gastroenterology. 2019;157:1690-1691.
    PubMed    


  47. GUO Y, Bai AP
    Plasticity of Th17 Cells Contributes to Crohn's Disease.
    Gastroenterology. 2019;157:1689.
    PubMed    


  48. COOK L, Stahl M, Han X, Nazli A, et al
    Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Gastroenterology. 2019;157:1584-1598.
    PubMed     Abstract available


  49. HARRIS MS, Wichary J, Zadnik M, Reinisch W, et al
    Competition for Clinical Trials in Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1457-1461.
    PubMed    


  50. BITTAR JM, Burton K, Rahnama S
    Verrucous Plaques of the Buttocks, Perineum, and Umbilicus.
    Gastroenterology. 2019;157:1480-1482.
    PubMed    


  51. DEBOURDEAU A, Boivineau L, Iltache S
    The Little Beast That Pretended to Be a Severe Crohn's Disease.
    Gastroenterology. 2019;157:1483-1484.
    PubMed    


    November 2019
  52. VAZIRI H, Anderson JC
    Stool DNA for the Detection of High Grade Dysplasia and Adenocarcinoma in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2019 Nov 20. pii: S0016-5085(19)41584.
    PubMed    


  53. FUKUNAGA S, Kusaba Y, Tsuruta O
    Use of endocytoscopy for ulcerative colitis surveillance: A case study.
    Gastroenterology. 2019 Nov 15. pii: S0016-5085(19)41567.
    PubMed    


  54. SANDBORN WJ, Peyrin-Biroulet L, Zhang J, Chiorean M, et al
    Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients with Ulcerative Colitis.
    Gastroenterology. 2019 Nov 8. pii: S0016-5085(19)41526.
    PubMed     Abstract available


  55. TORRES J
    Prediction of Inflammatory Bowel Disease: A Step Closer?
    Gastroenterology. 2019 Nov 5. pii: S0016-5085(19)41515.
    PubMed    


  56. ALAMEEL T, Al Sulais E
    Ustekinumab and Pregnancy: Continue or Cease Before You Conceive?
    Gastroenterology. 2019;157:1435.
    PubMed    


  57. BERNSTEIN CN
    Reply.
    Gastroenterology. 2019;157:1443-1444.
    PubMed    


  58. MAHADEVAN U, Fisher S, Riley L, Chambers C, et al
    Reply.
    Gastroenterology. 2019;157:1435-1436.
    PubMed    


  59. SHAH SC
    Friend or Foe in Inflammatory Bowel Disease Pathogenesis: Not All Infections Are Equal.
    Gastroenterology. 2019;157:1441-1442.
    PubMed    


  60. ZHU Y, Johnson LA, Rubin JM, Appelman H, et al
    Strain-Photoacoustic Imaging as a Potential Tool for Characterizing Intestinal Fibrosis.
    Gastroenterology. 2019;157:1196-1198.
    PubMed    


  61. KUO WT, Shen L, Zuo L, Shashikanth N, et al
    Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression.
    Gastroenterology. 2019;157:1323-1337.
    PubMed     Abstract available


  62. BAR-YOSEPH H, Pressman S, Blatt A, Gerassy Vainberg S, et al
    Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies.
    Gastroenterology. 2019;157:1338-1351.
    PubMed     Abstract available


  63. GUNTHER C, Ruder B, Stolzer I, Dorner H, et al
    Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1310-1322.
    PubMed     Abstract available


  64. HINDRYCKX P, Jairath V, Zou G, Feagan BG, et al
    Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1233-1244.
    PubMed     Abstract available


  65. ADEN K, Rehman A, Waschina S, Pan WH, et al
    Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1279-1292.
    PubMed     Abstract available


    October 2019
  66. PAPAMICHAEL K, Cheifetz AS
    Is It Prime Time for Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease?
    Gastroenterology. 2019;157:922-924.
    PubMed    


  67. GONCZI L, Bessissow T, Lakatos P
    Ver(s)ifying the Efficacy of Vedolizumab Therapy on Mucosal Healing in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:925-927.
    PubMed    


  68. GERASIMIDIS K, Svolos V, Nichols B, Papadopoulou R, et al
    Reply.
    Gastroenterology. 2019;157:1161-1162.
    PubMed    


  69. PARAMSOTHY S, Kaakoush NO
    Reply.
    Gastroenterology. 2019;157:1165-1166.
    PubMed    


  70. ASHTON JJ, Beattie RM
    Treatment of Active Crohn's Disease With an Ordinary Food-Based Diet That Replicates Exclusive Enteral Nutrition.
    Gastroenterology. 2019;157:1160-1161.
    PubMed    


  71. ALVARADO DM, Chen B, Iticovici M, Thaker AI, et al
    Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota.
    Gastroenterology. 2019;157:1093-1108.
    PubMed     Abstract available


  72. DANESE S, Sandborn WJ, Colombel JF, Vermeire S, et al
    Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Gastroenterology. 2019;157:1007-1018.
    PubMed     Abstract available


  73. LI K, Friedman JR, Chan D, Pollack P, et al
    Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1019-1031.
    PubMed     Abstract available


  74. DULAI PS, Peyrin-Biroulet L, Danese S, Sands BE, et al
    Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1032-1043.
    PubMed     Abstract available


  75. ASSA A, Matar M, Turner D, Broide E, et al
    Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring.
    Gastroenterology. 2019;157:985-996.
    PubMed     Abstract available


  76. LOWENBERG M, Vermeire S, Mostafavi N, Hoentjen F, et al
    Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:997-1006.
    PubMed     Abstract available


    September 2019
  77. COX SR, Lindsay JO, Fromentin S, Stagg AJ, et al
    Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Gastroenterology. 2019 Sep 27. pii: S0016-5085(19)41366.
    PubMed     Abstract available


  78. DE BACKER E, Bode H, Baert F
    New onset diffuse parenchymal lung disease in a 52-year old female with ulcerative colitis.
    Gastroenterology. 2019 Sep 24. pii: S0016-5085(19)41353.
    PubMed    


  79. SANDBORN WJ, Ferrante M, Bhandari BR, Berliba E, et al
    Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
    Gastroenterology. 2019 Sep 4. pii: S0016-5085(19)41300.
    PubMed     Abstract available


  80. XIAO L, Li XX, Chung HK, Kalakonda S, et al
    RNA-Binding Protein HuR Regulates Paneth Cell Function by Altering Membrane Localization of TLR2 via Post-transcriptional Control of CNPY3.
    Gastroenterology. 2019;157:731-743.
    PubMed     Abstract available


  81. PIOVANI D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, et al
    Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses.
    Gastroenterology. 2019;157:647-659.
    PubMed     Abstract available


    August 2019
  82. SANDBORN WJ, Baert F, Danese S, Krznaric Z, et al
    Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.
    Gastroenterology. 2019 Aug 27. pii: S0016-5085(19)41247.
    PubMed     Abstract available


  83. MONES RL
    Events Early in Life, But Not The Neonatal Period, Affect Risk For Later Development of Inflammatory Bowel Disease.
    Gastroenterology. 2019 Aug 20. pii: S0016-5085(19)41235.
    PubMed    


  84. SABINO J, Torres J, Colombel JF, Peter I, et al
    Neonatal life events and the risk of inflammatory bowel disease.
    Gastroenterology. 2019 Aug 20. pii: S0016-5085(19)41234.
    PubMed    


  85. MACK DR, Benchimol EI, Critch J, deBruyn J, et al
    Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease.
    Gastroenterology. 2019;157:320-348.
    PubMed     Abstract available


  86. LEVINE A, Wine E, Assa A, Sigall Boneh R, et al
    Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
    Gastroenterology. 2019;157:440-450.
    PubMed     Abstract available


  87. CHAPMAN TP, Tandon R, Brain O
    Another Case of Reflux Esophagitis?
    Gastroenterology. 2019;157:309-310.
    PubMed    


  88. ORDAS I, Rimola J, Alfaro I, Rodriguez S, et al
    Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's Disease.
    Gastroenterology. 2019;157:432-439.
    PubMed     Abstract available


    July 2019
  89. KELLERMAYER R
    Roseburia ssp.: Prime Candidates for Microbial Therapeutics in Inflammatory Bowel Disease.
    Gastroenterology. 2019 Jul 26. pii: S0016-5085(19)41122.
    PubMed    


  90. SMALLEY W, Falck-Ytter C, Carrasco-Labra A, Wani S, et al
    American Gastroenterological Association Guideline on Mild-to-Moderate Ulcerative Colitis on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
    Gastroenterology. 2019 Jul 11. pii: S0016-5085(19)41083.
    PubMed    


  91. DU M, Dong R, Zheng S
    Single-Cell RNA Sequencing of T Cells in Crohn's Disease.
    Gastroenterology. 2019;157:265-266.
    PubMed    


  92. ALBENBERG L, Brensinger CM, Wu Q, Gilroy E, et al
    A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn's Disease Flares.
    Gastroenterology. 2019;157:128-136.
    PubMed     Abstract available


  93. JASWANI TS, Hobson EM, Grider DJ
    A Complication of Crohn's Disease?
    Gastroenterology. 2019;157:31-33.
    PubMed    


    June 2019
  94. SABINO J, Lewis J, Colombel JF
    Treating Inflammatory Bowel Disease With Diet: A Taste Test.
    Gastroenterology. 2019 Jun 27. pii: S0016-5085(19)41036.
    PubMed    


  95. D'HAENS G, Rieder F, Feagan BG, Higgins PDR, et al
    Challenges in the Pathophysiology, Diagnosis and Management of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Gastroenterology. 2019 Jun 26. pii: S0016-5085(19)41035.
    PubMed     Abstract available


  96. ALTEPETER T, Wertheimer E, Lee JJ
    Expediting Drug Development for Pediatric Inflammatory Bowel Disease: A Workshop to Identify Barriers and Move Forward.
    Gastroenterology. 2019 Jun 20. pii: S0016-5085(19)41029.
    PubMed    


  97. CHEN JCY, Halawi H, Loftus CG
    New Ascites and Omental Thickening in Ulcerative Colitis.
    Gastroenterology. 2019 Jun 14. pii: S0016-5085(19)41014.
    PubMed    


  98. TORRES J, Peter I
    Neonatal Exposures and Risk of Inflammatory Bowel Disease: When Does the Clock Start Ticking?
    Gastroenterology. 2019 Jun 13. pii: S0016-5085(19)41007.
    PubMed    


  99. LIGHTNER AL
    The Present State and Future Direction of Regenerative Medicine for Perianal Crohn's Disease.
    Gastroenterology. 2019;156:2128-2130.
    PubMed    


  100. COHEN LJ, Cho JH, Gevers D, Chu H, et al
    Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases.
    Gastroenterology. 2019;156:2174-2189.
    PubMed     Abstract available


  101. SOMINENI HK, Venkateswaran S, Kilaru V, Marigorta UM, et al
    Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation.
    Gastroenterology. 2019;156:2254-2265.
    PubMed     Abstract available


  102. TIAN Y, Xu J, Li Y, Zhao R, et al
    MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice.
    Gastroenterology. 2019;156:2281-2296.
    PubMed     Abstract available


  103. DIGE A, Hougaard HT, Agnholt J, Pedersen BG, et al
    Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2019;156:2208-2216.
    PubMed     Abstract available


  104. BERNSTEIN CN, Burchill C, Targownik LE, Singh H, et al
    Events Within the First Year of Life, but Not the Neonatal Period, Affect Risk for Later Development of Inflammatory Bowel Diseases.
    Gastroenterology. 2019;156:2190-2197.
    PubMed     Abstract available


  105. SERRERO M, Grimaud F, Philandrianos C, Visee C, et al
    Long-term Safety and Efficacy of Local Microinjection Combining Autologous Microfat and Adipose-Derived Stromal Vascular Fraction for the Treatment of Refractory Perianal Fistula in Crohn's Disease.
    Gastroenterology. 2019;156:2335-2337.
    PubMed    


    May 2019
  106. GOLDBERG R, Scotta C, Cooper D, Nissim-Eliraz E, et al
    Correction of Defective T-Regulatory Cells From Patients With Crohn's Disease by Ex Vivo Ligation of Retinoic Acid Receptor-alpha.
    Gastroenterology. 2019;156:1775-1787.
    PubMed     Abstract available


    April 2019
  107. GRACIE DJ, Ford AC
    Depression, Antidepressants, and Inflammatory Bowel Disease: Implications for Future Models of Care.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36720.
    PubMed    


  108. FRIEDMAN S, Norgard BM
    Confirming Complexity: Assessing Environmental and Genetic Risk Factors for Inflammatory Bowel Disease.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36723.
    PubMed    


  109. KINNUCAN J, Binion D, Cross R, Evans E, et al
    Inflammatory Bowel Disease Care Referral Pathway.
    Gastroenterology. 2019 Apr 10. pii: S0016-5085(19)35665.
    PubMed    


  110. COWARD S, Clement F, Benchimol EI, Bernstein CN, et al
    Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data.
    Gastroenterology. 2019;156:1345-1353.
    PubMed     Abstract available


  111. SVOLOS V, Hansen R, Nichols B, Quince C, et al
    Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
    Gastroenterology. 2019;156:1354-1367.
    PubMed     Abstract available


  112. MAHMOUD R, Shah SC, Ten Hove JR, Torres J, et al
    No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2019;156:1333-1344.
    PubMed     Abstract available


    March 2019
  113. GROSEN A, Bungum M, Hvas CL, Julsgaard M, et al
    Vedolizumab Does Not Impair Sperm DNA Integrity in Men With Inflammatory Bowel Disease.
    Gastroenterology. 2019 Mar 5. pii: S0016-5085(19)32509.
    PubMed    


  114. TSANG L, Banerjee N, Tabibian JH
    Not your typical inflammatory bowel disease flare: diarrhea and weight loss masquerading as recrudescence of ulcerative colitis.
    Gastroenterology. 2019 Mar 1. pii: S0016-5085(19)32503.
    PubMed    


  115. SCHEIBE K, Kersten C, Schmied A, Vieth M, et al
    Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
    Gastroenterology. 2019;156:1082-1097.
    PubMed     Abstract available


  116. HU X, Deng J, Yu T, Chen S, et al
    ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
    Gastroenterology. 2019;156:1098-1111.
    PubMed     Abstract available


  117. WYNNE B, McHugh L, Gao W, Keegan D, et al
    Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2019;156:935-945.
    PubMed     Abstract available


  118. FEHILY SR, Partsanis NM, Christensen B
    Cough in the Immunosuppressed Patient.
    Gastroenterology. 2019;156:e3-e4.
    PubMed    


    February 2019
  119. KORZENIK J
    Don't Worry, Be Happy: Psychological interventions in Inflammatory Bowel Disease.
    Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30386.
    PubMed    


  120. PARISINOS CA
    Reply.
    Gastroenterology. 2019;156:824.
    PubMed    


  121. UNIKEN VENEMA WT, Voskuil MD, Vila AV, van der Vries G, et al
    Single-Cell RNA Sequencing of Blood and Ileal T Cells From Patients With Crohn's Disease Reveals Tissue-Specific Characteristics and Drug Targets.
    Gastroenterology. 2019;156:812-815.
    PubMed    


  122. OLEN O, Askling J, Sachs MC, Frumento P, et al
    Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population.
    Gastroenterology. 2019;156:614-622.
    PubMed     Abstract available


  123. TANG Y, Reissig S, Glasmacher E, Regen T, et al
    Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
    Gastroenterology. 2019;156:692-707.
    PubMed     Abstract available


    January 2019

  124. Mild-to-Moderate Ulcerative Colitis (UC) Clinical Decision Support Tool.
    Gastroenterology. 2019 Jan 23. pii: S0016-5085(19)30099.
    PubMed    


  125. CROSS R, Ko CW, Singh S
    Mild-to-Moderate Ulcerative Colitis Guideline.
    Gastroenterology. 2019 Jan 23. pii: S0016-5085(19)30097.
    PubMed    



  126. Management of Mild-to-Moderate Ulcerative Colitis: Patient Guide.
    Gastroenterology. 2019 Jan 19. pii: S0016-5085(19)30096.
    PubMed    


  127. MAHADEVAN U, Robinson C, Bernasko N, Boland B, et al
    Inflammatory Bowel Disease (IBD) in Pregnancy Clinical Care Pathway - A Report from the American Gastroenterological Association IBD Parenthood Project Working Group.
    Gastroenterology. 2019 Jan 16. pii: S0016-5085(18)35437.
    PubMed    


  128. YE L, Jiang Z, Cao Q
    Massive bleeding and perforation with endoscopic multiple deep ulcers in a patient with ulcerative colitis after colectomy.
    Gastroenterology. 2019 Jan 10. pii: S0016-5085(19)30029.
    PubMed    


  129. DE BOER NKH
    Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones.
    Gastroenterology. 2019;156:11-14.
    PubMed    


  130. LEHLE AS, Farin HF, Marquardt B, Michels BE, et al
    Intestinal Inflammation and Dysregulated Immunity in Patients With Inherited Caspase-8 Deficiency.
    Gastroenterology. 2019;156:275-278.
    PubMed    


  131. BORGERINK MMH, Weersma RK, Visschedijk MC
    A Case Report of a Young Adult With Progressive Bloody Diarrhea, Protein-Losing Enteropathy, and Extended Polyposis Coli.
    Gastroenterology. 2019;156:e10-e11.
    PubMed    


  132. HANAUER SB, Sandborn WJ, Lichtenstein GR
    Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
    Gastroenterology. 2019;156:36-42.
    PubMed     Abstract available


    December 2018
  133. KO CW, Singh S, Feuerstein JD, Falck-Ytter C, et al
    American Gastroenterological Association Institute Guideline on the Management of Mild-Moderate Ulcerative Colitis.
    Gastroenterology. 2018 Dec 18. pii: S0016-5085(18)35407.
    PubMed    


  134. SINGH S, Feuerstein JD, Binion DG, Tremaine WJ, et al
    American Gastroenterological Association Technical Review on the Management of Mild to Moderate Ulcerative Colitis.
    Gastroenterology. 2018 Dec 18. pii: S0016-5085(18)35406.
    PubMed     Abstract available


  135. PARAMSOTHY S, Nielsen S, Kamm MA, Deshpande NP, et al
    Specific Bacteria and Metabolites Associated with Response to Fecal Microbiota Transplantation in Patients with Ulcerative Colitis.
    Gastroenterology. 2018 Dec 6. pii: S0016-5085(18)35387.
    PubMed     Abstract available


  136. PHILIPOSE J, El Douaihy Y, Liliane DK
    An Unusual Case of Bloody Diarrhea in a Young Man.
    Gastroenterology. 2018;155:1695-1696.
    PubMed    


    November 2018
  137. SANDBORN WJ, Cyrille M, Hansen MB, Feagan BG, et al
    Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35283.
    PubMed     Abstract available


  138. BIANCHERI P, Watson AJM
    High Mucosal Plasma Cell Numbers and Low Serum TREM-1 Levels May Predict Nonresponsiveness to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35291.
    PubMed    


  139. LIU G, Jin S, Jiang Q
    Interleukin 6 receptor and inflammatory bowel disease: a Mendelian randomization study.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35266.
    PubMed    


  140. ARGYRIOU K, Khan M, Samuel S
    Multiple Unusual Ulcerated Skin Lesions in a Crohn's Disease Patient.
    Gastroenterology. 2018;155:e17-e18.
    PubMed    


    October 2018
  141. GODEFROY E, Alameddine J, Montassier E, Mathe J, et al
    Expression of CCR6 and CXCR6 by Gut-Derived CD4(+)/CD8alpha(+) T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:1205-1217.
    PubMed     Abstract available


  142. SHAH SC, Khalili H, Gower-Rousseau C, Olen O, et al
    Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries.
    Gastroenterology. 2018;155:1079-1089.
    PubMed     Abstract available


  143. RUTGEERTS P, Gasink C, Chan D, Lang Y, et al
    Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.
    Gastroenterology. 2018;155:1045-1058.
    PubMed     Abstract available


  144. GOLD SL, Magro C, Scherl E
    A Unique Infusion Reaction to Vedolizumab in a Patient With Crohn's Disease.
    Gastroenterology. 2018;155:981-982.
    PubMed    


    September 2018
  145. KELLY CP, Wilcox MH, Glerup H, Aboo N, et al
    Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease.
    Gastroenterology. 2018 Sep 15. pii: S0016-5085(18)34757.
    PubMed    


  146. SORRENTINO DR
    Therapeutic Targets in Inflammatory Bowel Disease: Are We Getting the Point Across?
    Gastroenterology. 2018 Sep 14. pii: S0016-5085(18)34773.
    PubMed    


  147. DULAI PS
    Methotrexate Monotherapy for Induction and Maintenance of Clinical Remission in Ulcerative Colitis: Dead on Arrival.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34940.
    PubMed    


  148. KANEIDER NC, Kaser A
    Personalized Treatment in Inflammatory Bowel Disease: For Another Time.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34937.
    PubMed    


  149. DULAI PS, Boland BS, Singh S, Chaudrey K, et al
    Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
    Gastroenterology. 2018;155:687-695.
    PubMed     Abstract available


  150. MATRO R, Martin CF, Wolf D, Shah SA, et al
    Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
    Gastroenterology. 2018;155:696-704.
    PubMed     Abstract available


  151. CLERC F, Novokmet M, Dotz V, Reiding KR, et al
    Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:829-843.
    PubMed     Abstract available


  152. VANDUSSEN KL, Stojmirovic A, Li K, Liu TC, et al
    Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease.
    Gastroenterology. 2018;155:815-828.
    PubMed     Abstract available


  153. CHEBLI JMF, de Oliveira Moreira B, da Rocha Ribeiro TC
    An Unusual Cause of Skin Rash in Crohn's Disease.
    Gastroenterology. 2018;155:618-620.
    PubMed    


    August 2018
  154. SHAH SC, Faith J, Colombel JF
    Microbial-host interactions in inflammatory bowel disease, functional bowel disease, obesity and obesity-related metabolic disease.
    Gastroenterology. 2018 Aug 31. pii: S0016-5085(18)34765.
    PubMed    


  155. KOUNTOURAS J, Polyzos SA, Deretzi G
    Multiple Bi-directionality Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2018 Aug 14. pii: S0016-5085(18)34877.
    PubMed    


  156. WEERSMA RK, Xavier RJ, Vermeire S, Barrett JC, et al
    "Multi-omics analyses to deliver the most effective treatment to every patient with inflammatory bowel disease".
    Gastroenterology. 2018 Aug 2. pii: S0016-5085(18)34827.
    PubMed    


  157. LE L, Fung BM, Tabibian JH
    Capsule Endoscopy for Refractory Iron Deficiency Anemia in Crohn's Disease: Captivating Pathology, Hybrid Therapy.
    Gastroenterology. 2018;155:276-277.
    PubMed    


  158. KIRCHGESNER J, Lemaitre M, Carrat F, Zureik M, et al
    Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:337-346.
    PubMed     Abstract available


    July 2018
  159. NISHIO M, Hirooka K, Doi Y
    Pulmonary Arterial Hypertension Associated With the Chinese Herb Indigo Naturalis for Ulcerative Colitis: It May Be Reversible.
    Gastroenterology. 2018 Jul 9. pii: S0016-5085(18)34649.
    PubMed    


  160. TELESCO SE, Brodmerkel C, Zhang H, Kim LL, et al
    Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-label Trial of Patients With Ulcerative Colitis.
    Gastroenterology. 2018 Jul 4. pii: S0016-5085(18)34719.
    PubMed     Abstract available


  161. LIU B, Dong K, Dong R
    The Diagnosis Effect of DNA Methylation in Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:229.
    PubMed    


  162. GENG H, Bu HF, Liu F, Wu L, et al
    In Inflamed Intestinal Tissues and Epithelial Cells, Interleukin 22 Signaling Increases Expression of H19 Long Noncoding RNA, Which Promotes Mucosal Regeneration.
    Gastroenterology. 2018;155:144-155.
    PubMed     Abstract available


  163. DANESE S, Bonovas S, Lopez A, Fiorino G, et al
    Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.
    Gastroenterology. 2018;155:76-87.
    PubMed     Abstract available


  164. DHILLON AS, Johnston EL, Sanderson JD
    A Case of Unusual Ileal Discoloration.
    Gastroenterology. 2018;155:e1-e2.
    PubMed    


    June 2018
  165. LYNN AM, Loftus EV Jr
    Illuminating the Black Box: The Real Risk of Serious Infection with Inflammatory Bowel Disease Therapies.
    Gastroenterology. 2018 Jun 29. pii: S0016-5085(18)34695.
    PubMed    


  166. HERFARTH H, Barnes EL, Valentine JF, Hanson J, et al
    Methotrexate is not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis.
    Gastroenterology. 2018 Jun 29. pii: S0016-5085(18)34688.
    PubMed     Abstract available


  167. QUARANTA M, Wilson R, Serra EG, Pandey S, et al
    Genomics Identifies XIAP Deficiency in an Adult Patient With Inflammatory Bowel Disease: The Clinical and Health Care Impact.
    Gastroenterology. 2018 Jun 9. pii: S0016-5085(18)34529.
    PubMed    


  168. NUNES G, Patita M, Roque Ramos L
    An Uncommon Clinical Sign in a Patient with Ulcerative Colitis.
    Gastroenterology. 2018 Jun 5. pii: S0016-5085(18)34608.
    PubMed    


  169. AMININEJAD L, Charloteaux B, Theatre E, Liefferinckx C, et al
    Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's Disease.
    Gastroenterology. 2018;154:2165-2177.
    PubMed     Abstract available


  170. DENSON LA, Jurickova I, Karns R, Shaw KA, et al
    Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease.
    Gastroenterology. 2018;154:2097-2110.
    PubMed     Abstract available


  171. KHOURY T, Israeli E, Yaari S
    Unfolding the Diagnosis: Rare Endoscopic Features of Unusual Cause of Colitis.
    Gastroenterology. 2018;154:e7-e8.
    PubMed    


    May 2018
  172. PARISINOS CA, Serghiou S, Katsoulis M, George MJ, et al
    Variation in Interleukin 6 Receptor Gene Associates with Risk of Crohn's Disease and Ulcerative Colitis.
    Gastroenterology. 2018 May 15. pii: S0016-5085(18)34542.
    PubMed     Abstract available


  173. UHLIG HH, Booth C
    Inflammatory Bowel Disease and Immune Defects: A Spectrum of Genetic Variants and Clinical Pathogenicity.
    Gastroenterology. 2018 May 5. pii: S0016-5085(18)34485.
    PubMed    


  174. ADEDOKUN OJ, Xu Z, Gasink C, Jacobstein D, et al
    Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.
    Gastroenterology. 2018;154:1660-1671.
    PubMed     Abstract available


  175. GRACIE DJ, Guthrie EA, Hamlin PJ, Ford AC, et al
    Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2018;154:1635-1646.
    PubMed     Abstract available


  176. YANG LS, Dowling D
    A Rare Complication of Infliximab.
    Gastroenterology. 2018;154:e5-e6.
    PubMed    


  177. DEBOURDEAU A, Bozon A, Altwegg R
    An Uncommon Cause of Feverish Swelling in a Patient With Crohn's Disease.
    Gastroenterology. 2018;154:1584-1585.
    PubMed    


    April 2018
  178. MAHAKKANUKRAUH P, Sinthubua A, Das S
    Methylated MicroRNA Biomarkers for Identifying Ulcerative Colitis-Associated Colorectal Cancers.
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30311.
    PubMed    


  179. BOSCH S, de Meij TGJ, de Boer NK
    Altered Tryptophan Levels in Patients With Inflammatory Bowel Disease Owing to Colonic Leakage, Metabolism, or Malabsorption?
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30308.
    PubMed    


  180. CHARPENTIER C, Kottler D, Fite C, Pelletier AL, et al
    A Surprising Granulomatous Cheilitis.
    Gastroenterology. 2018;154:1239-1240.
    PubMed    


  181. D'HAENS G, Vermeire S, Lambrecht G, Baert F, et al
    Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.
    Gastroenterology. 2018;154:1343-1351.
    PubMed     Abstract available


  182. SIMURINA M, de Haan N, Vuckovic F, Kennedy NA, et al
    Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.
    Gastroenterology. 2018;154:1320-1333.
    PubMed     Abstract available


  183. PANES J, Garcia-Olmo D, Van Assche G, Colombel JF, et al
    Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2018;154:1334-1342.
    PubMed     Abstract available


  184. ROY S, Esmaeilniakooshkghazi A, Patnaik S, Wang Y, et al
    Villin-1 and Gelsolin Regulate Changes in Actin Dynamics That Affect Cell Survival Signaling Pathways and Intestinal Inflammation.
    Gastroenterology. 2018;154:1405-1420.
    PubMed     Abstract available


    March 2018
  185. MAHADEVAN U, Silverberg MS
    Inflammatory Bowel Disease.
    Gastroenterology. 2018 Mar 14. pii: S0016-5085(18)30008.
    PubMed    


  186. BRUINING DH, Zimmermann EM, Loftus EV Jr., Sandborn WJ, et al
    Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease.
    Gastroenterology. 2018;154:1172-1194.
    PubMed     Abstract available


    February 2018
  187. LEY D, Jones J, Parrish J, Salih S, et al
    Methotrexate Reduces DNA Integrity in Sperm From Men with Inflammatory Bowel Disease.
    Gastroenterology. 2018 Feb 23. pii: S0016-5085(18)30229.
    PubMed     Abstract available


  188. PAPAMICHAEL K, Osterman MT, Siegel CA, Melmed GY, et al
    Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
    Gastroenterology. 2018 Feb 9. pii: S0016-5085(18)30006.
    PubMed    


  189. YE BD
    Introducing Traditional Herbal Medicine into Conventional Health Care in Treating Ulcerative Colitis: Primum Non Nocere.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30160.
    PubMed    


  190. MENEES SB, Almario CV, Spiegel BMR, Chey WD, et al
    Prevalence of and Factors Associated with Fecal Incontinence-Results From a Population-based Survey.
    Gastroenterology. 2018 Feb 3. pii: S0016-5085(18)30144.
    PubMed     Abstract available


  191. EVERHOV AH, Halfvarson J, Myrelid P, Sachs MC, et al
    Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Gastroenterology. 2018;154:518-528.
    PubMed     Abstract available


  192. HOWELL KJ, Kraiczy J, Nayak KM, Gasparetto M, et al
    DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
    Gastroenterology. 2018;154:585-598.
    PubMed     Abstract available


    January 2018
  193. JABOLI F, Pouillon L, Bossuyt P, Danese S, et al
    Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30101.
    PubMed    


  194. FEAGAN BG, Sands BE, Rossiter G, Li X, et al
    Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's Disease.
    Gastroenterology. 2018;154:61-64.
    PubMed     Abstract available


    December 2017
  195. LIU L, Nishihara R, Qian ZR, Tabung FK, et al
    Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.
    Gastroenterology. 2017;153:1517-1530.
    PubMed     Abstract available


  196. NIKOLAUS S, Schulte B, Al-Massad N, Thieme F, et al
    Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Gastroenterology. 2017;153:1504-1516.
    PubMed     Abstract available


    November 2017
  197. DAI C, Jiang M, Sun MJ
    Clostridium difficile Infection among Individuals With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Nov 23. pii: S0016-5085(17)36334.
    PubMed    


  198. NAGANUMA M, Sugimoto S, Mitsuyama K, Kobayashi T, et al
    Efficacy of Indigo naturalis in a Multicenter Randomized Controlled Trial of Patients with Ulcerative Colitis.
    Gastroenterology. 2017 Nov 22. pii: S0016-5085(17)36382.
    PubMed     Abstract available


  199. DULAI PS, Singh S, Ohno-Machado L, Sandborn WJ, et al
    Population Health Management for Inflammatory Bowel Disease.
    Gastroenterology. 2017 Nov 6. pii: S0016-5085(17)36337.
    PubMed     Abstract available


  200. KUMAR A, Chatterjee I, Gujral T, Alakkam A, et al
    Activation of Nuclear Factor-kappaB by Tumor Necrosis Factor in Intestinal Epithelial Cells and Mouse Intestinal Epithelia Reduces Expression of the Chloride Transporter SLC26A3.
    Gastroenterology. 2017;153:1338-1350.
    PubMed     Abstract available


  201. HEGAZY AN, West NR, Stubbington MJT, Wendt E, et al
    Circulating and Tissue-Resident CD4(+) T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation.
    Gastroenterology. 2017;153:1320-1337.
    PubMed     Abstract available


    October 2017
  202. GRACIE DJ, Ford AC
    A Bidirectional Relationship Between Symptom Reporting and Perceived Stress, But Not Disease Activity, in Inflammatory Bowel Disease: More Questions Than Answers?
    Gastroenterology. 2017 Oct 5. pii: S0016-5085(17)36194.
    PubMed    


  203. JULSGAARD M, Kjeldsen J, Bibby BM, Brock B, et al
    Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Oct 5. pii: S0016-5085(17)36132.
    PubMed    


    September 2017
  204. KESAR V, Swaminath A
    Hepatic masses in a patient in Inflammatory bowel disease.
    Gastroenterology. 2017 Sep 9. pii: S0016-5085(17)36140.
    PubMed    


  205. CHAPMAN S, El-Matary W
    Screening for Epstein-Barr Virus Status and Risk of Hemophagocytic Lymphohistiocytosis in Children With Inflammatory Bowel Disease on Azathioprine.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)36033.
    PubMed    


  206. BARNES EL, Herfarth HH
    The Usefulness of Serologic Testing for Epstein-Barr Virus Before Initiation of Therapy for Inflammatory Bowel Disease.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)36035.
    PubMed    


  207. VANDE CASTEELE N, Herfarth H, Katz J, Falck-Ytter Y, et al
    American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases.
    Gastroenterology. 2017;153:835-857.
    PubMed     Abstract available


  208. WELLMAN AS, Metukuri MR, Kazgan N, Xu X, et al
    Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota.
    Gastroenterology. 2017;153:772-786.
    PubMed     Abstract available


    August 2017
  209. TOIYAMA Y, Okugawa Y, Tanaka K, Araki T, et al
    A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients with Ulcerative Colitis-associated Colorectal Cancer.
    Gastroenterology. 2017 Aug 25. pii: S0016-5085(17)36070.
    PubMed     Abstract available


  210. TSAI JH, Rabinovitch PS, Huang D, Small T, et al
    Association of Aneuploidy and Flat Dysplasia With Development of High-Grade Dysplasia or Colorectal Cancer in Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Aug 23. pii: S0016-5085(17)36064.
    PubMed     Abstract available


  211. FEUERSTEIN JD, Nguyen GC, Kupfer SS, Falck-Ytter Y, et al
    Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
    Gastroenterology. 2017 Aug 2. pii: S0016-5085(17)35963.
    PubMed    



  212. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Clinical Decision Support Tool.
    Gastroenterology. 2017 Aug 1. pii: S0016-5085(17)35970.
    PubMed    


    July 2017

  213. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Patient Guide.
    Gastroenterology. 2017 Jul 31. pii: S0016-5085(17)35968.
    PubMed    


  214. SURESH S, Govani SM, Waljee AK
    Ten Hove JR et al. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy. Endoscopy. 2017 Feb;49(2):161-168.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35957.
    PubMed    


  215. POUILLON L, Bossuyt P, Peyrin-Biroulet L
    Tofacitinib is the right OCTAVE for ulcerative colitis.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35958.
    PubMed    


  216. PARLATO M, Charbit-Henrion F, Hayes P, Tiberti A, et al
    First Identification of Biallelic Inherited DUOX2 Inactivating Mutations as a Cause of Very Early Onset Inflammatory Bowel Disease.
    Gastroenterology. 2017 Jul 3. pii: S0016-5085(17)35484.
    PubMed    


  217. GONSKY R, Fleshner P, Deem RL, Biener-Ramanujan E, et al
    Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.
    Gastroenterology. 2017;153:219-232.
    PubMed     Abstract available


  218. DIETZ AB, Dozois EJ, Fletcher JG, Butler GW, et al
    Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2017;153:59-62.
    PubMed     Abstract available


  219. SANDS BE, Chen J, Feagan BG, Penney M, et al
    Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.
    Gastroenterology. 2017;153:77-86.
    PubMed     Abstract available


    June 2017
  220. DANESE S, Fiorino G, Peyrin-Biroulet L
    Filgotinib in Crohn Disease: JAK Is Back.
    Gastroenterology. 2017 Jun 24. pii: S0016-5085(17)35825.
    PubMed    


  221. HOLVOET T, Devriese S, Castermans K, Boland S, et al
    Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local Rho kinase inhibitor.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35798.
    PubMed     Abstract available


  222. CHANG J, Leong RW, Wasinger V, Ip M, et al
    Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Gastroenterology. 2017 Jun 7. pii: S0016-5085(17)35731.
    PubMed     Abstract available


  223. KANIS SL, van der Woude CJ
    Endoscopy for Inflammatory Bowel Disease During Pregnancy: Only When There Is a Strong Indication.
    Gastroenterology. 2017 Jun 1. pii: S0016-5085(17)35603.
    PubMed    


    May 2017
  224. GRACIE DJ, Ford AC
    Irritable bowel syndrome-type symptoms are associated with psychological co-morbidity, reduced quality of life, and healthcare utilization in patients with inflammatory bowel disease.
    Gastroenterology. 2017 May 29. pii: S0016-5085(17)35679.
    PubMed    


  225. YADAV P, Ellinghaus D, Remy G, Freitag-Wolf S, et al
    Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice.
    Gastroenterology. 2017 May 12. pii: S0016-5085(17)35596.
    PubMed     Abstract available


  226. SINGH H, Nugent Z, Yu BN, Lix LM, et al
    Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35554.
    PubMed     Abstract available


  227. MISRA R, Arebi N
    Re: Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35405.
    PubMed    


  228. LEONG RW, Ooi M, Corte C, Yau Y, et al
    Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:1337-1344.
    PubMed     Abstract available


    April 2017
  229. MAHADEVAN U
    How To Get an Education in Inflammatory Bowel Disease During Fellowship: Expectations and Realities.
    Gastroenterology. 2017 Apr 28. pii: S0016-5085(17)35540.
    PubMed    


    March 2017
  230. CHIRIAC MT, Buchen B, Wandersee A, Hundorfean G, et al
    Activation of Epithelial STAT1 by Interleukin 28 Controls Mucosal Healing in Mice with Colitis and is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Mar 22. pii: S0016-5085(17)30322.
    PubMed     Abstract available


  231. WEISMULLER TJ, Trivedi PJ, Bergquist A, Imam M, et al
    Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Gastroenterology. 2017 Mar 5. pii: S0016-5085(17)30236.
    PubMed     Abstract available


    February 2017
  232. HYAMS JS, Dubinsky MC, Baldassano RN, Colletti RB, et al
    Infliximab not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30148.
    PubMed     Abstract available


  233. ENNS RA, Hookey L, Armstrong D, Bernstein CN, et al
    Clinical Practice Guidelines for the Use of Video Capsule Endoscopy.
    Gastroenterology. 2017;152:497-514.
    PubMed     Abstract available


  234. HAWKEY CJ, Hommes DW
    Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?
    Gastroenterology. 2017;152:389-397.
    PubMed     Abstract available


  235. REGUEIRO M, Greer JB, Szigethy E
    Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:430-439.
    PubMed     Abstract available


  236. LEWIS JD, Abreu MT
    Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:398-414.
    PubMed     Abstract available


  237. ABRAHAM C, Dulai PS, Vermeire S, Sandborn WJ, et al
    Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:374-388.
    PubMed     Abstract available


  238. SARTOR RB, Wu GD
    Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
    Gastroenterology. 2017;152:327-339.
    PubMed     Abstract available


  239. MAHADEVAN U, McConnell RA, Chambers CD
    Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017;152:451-462.
    PubMed     Abstract available


  240. VELAYOS F, Kathpalia P, Finlayson E
    Changing Paradigms in Detection of Dysplasia and Management of Patients With Inflammatory Bowel Disease: Is Colectomy Still Necessary?
    Gastroenterology. 2017;152:440-450.
    PubMed     Abstract available


  241. PANES J, Jairath V, Levesque BG
    Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:362-373.
    PubMed     Abstract available


  242. CHEIFETZ AS, Gianotti R, Luber R, Gibson PR, et al
    Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:415-429.
    PubMed     Abstract available


  243. STAPPENBECK TS, McGovern DP
    Paneth Cell Alterations in the Development and Phenotype of Crohn's Disease.
    Gastroenterology. 2017;152:322-326.
    PubMed     Abstract available


  244. COLOMBEL JF, Narula N, Peyrin-Biroulet L
    Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:351-361.
    PubMed     Abstract available


  245. RIEDER F, Fiocchi C, Rogler G
    Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:340-350.
    PubMed     Abstract available


    January 2017
  246. ROSEN MJ, Karns R, Vallance JE, Bezold R, et al
    Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-only Crohn's Disease in Treatment-naive Pediatric Patients.
    Gastroenterology. 2017 Jan 26. pii: S0016-5085(17)30073.
    PubMed     Abstract available


  247. POPP V, Gerlach K, Mott S, Turowska A, et al
    Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
    Gastroenterology. 2017;152:176-192.
    PubMed     Abstract available


    December 2016
  248. VAZIRI H, Anderson JC
    Is Chromoendoscopy Superior to Standard Colonoscopy for Long-term Surveillance of Patients With Inflammatory Bowel Disease?
    Gastroenterology. 2016 Dec 28. pii: S0016-5085(16)35525.
    PubMed    


  249. COLOMBEL JF, Mahadevan U
    Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms.
    Gastroenterology. 2016 Dec 10. pii: S0016-5085(16)35464.
    PubMed    


    November 2016
  250. SHIRAISHI T, Shoji H, Akazawa Y
    Gingival Carcinoma in a Patient With Ulcerative Colitis?
    Gastroenterology. 2016 Nov 25. pii: S0016-5085(16)34955.
    PubMed    


  251. FRANKE A
    Inflammatory Bowel Disease: A Global Disease That Needs a Broader Ensemble of Populations.
    Gastroenterology. 2016 Nov 23. pii: S0016-5085(16)35395.
    PubMed    


  252. YANG Y, Owyang C, Wu GD
    East Meets West: The Increasing Incidence of Inflammatory Bowel Disease in Asia as a Paradigm for Environmental Effects on the Pathogenesis of Immune-Mediated Disease.
    Gastroenterology. 2016 Nov 1. pii: S0016-5085(16)35281.
    PubMed    


    October 2016
  253. EL-MATARY W
    Risk of Attenuated Live Vaccine-Induced Infection in Infants of Mothers Receiving Anti-Tumor Necrosis Factor Agents for Inflammatory Bowel Disease.
    Gastroenterology. 2016 Oct 31. pii: S0016-5085(16)35187.
    PubMed    


  254. SANCHEZ-GUILLEN L, Blanco-Antona F, Millan-Scheiding M
    An Unusual Case of Intestinal Obstruction in Ulcerative Colitis.
    Gastroenterology. 2016 Oct 31. pii: S0016-5085(16)34813.
    PubMed    


  255. SMITH PD, Elson CO
    Elucidating the Role of the IL-10 Receptor in Mucosal Inflammation Uncovers a Potential Treatment for Infantile Inflammatory Bowel Disease.
    Gastroenterology. 2016 Oct 27. pii: S0016-5085(16)35279.
    PubMed    


  256. KAPLAN GG, Ng SC
    Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.
    Gastroenterology. 2016 Oct 25. pii: S0016-5085(16)35267.
    PubMed     Abstract available


    September 2016
  257. BAMIAS G, Rivera-Nieves J
    Targeting S1P Receptors, A New Mechanism of Action for Inflammatory Bowel Disease Therapy.
    Gastroenterology. 2016 Sep 29. pii: S0016-5085(16)35120.
    PubMed    


  258. KHANNA R, Jairath V
    Treatment Targets in Ulcerative Colitis.
    Gastroenterology. 2016 Sep 29. pii: S0016-5085(16)35123.
    PubMed    


  259. BRANT SR, Okou DT, Simpson CL, Cutler DJ, et al
    Genome-wide Association Study Identifies African-Specific Susceptibility Loci in African Americans with Inflammatory Bowel Disease.
    Gastroenterology. 2016 Sep 28. pii: S0016-5085(16)35127.
    PubMed     Abstract available


  260. PIPER MS, Waljee A, Stidham R
    Operate or Medicate: Understanding Surgical Risks in the Elderly with Inflammatory Bowel Disease.
    Gastroenterology. 2016 Sep 28. pii: S0016-5085(16)35122.
    PubMed    


    May 2016
  261. SCHREIBER S, Vermeire S
    How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel Diseases.
    Gastroenterology. 2016;150:1061-6.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: